Gene delivery system: A developing arena of study for the new era of medicine

Recent Patents on DNA and Gene Sequences

Volumn 6, Issue 1, 2012, Pages 2-9

  Khan, Saifur Rahman ^a   Ganguly, Advaita ^a   Malabadi, Ravindra B ^a   Sunwoo, Hoon H ^a   Suresh, Mavanur R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Nanoparticles; Plasmid DNA; Targeting; Transfection; Vaccines; Vectors

Indexed keywords

ADENOVIRUS VECTOR; AMPICILLIN; CHITOSAN; COPOLYMER; GAG PROTEIN; HERPESVIRUS VECTOR; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR; PLASMID DNA; POLYAMIDOAMINE; POLYLYSINE; POLYORNITHINE; RETROVIRUS VECTOR; VIRUS ENVELOPE PROTEIN;

AMPLICON; ANTIBIOTIC RESISTANCE; CYTOLYSIS; DNA REPLICATION ORIGIN; ENDOCYTOSIS; ESCHERICHIA COLI; EX VIVO GENE TRANSFER; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE REPLACEMENT THERAPY; GENE SILENCING; GENE VECTOR; GENETIC REGULATION; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; INVERTED TERMINAL REPEAT; LENTIVIRINAE; LONG TERMINAL REPEAT; MEDICAL ETHICS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OPEN READING FRAME; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RESEARCH ETHICS; REVIEW; SEMLIKI FOREST ALPHAVIRUS; SINDBIS VIRUS; TRANSGENE; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTACHMENT;

ADENOVIRIDAE; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; NANOPARTICLES; PLASMIDS; POLYMERS; RETROVIRIDAE; SIMPLEXVIRUS;

EID: 84857127506     PISSN: 18722156     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221512799303145     Document Type: Review

References (70)

1. Hamilton MP. The new genetics and the future of man. Grand Rapids,: Eerdmans, 1972.
2. Friedmann T, Roblin R. Gene therapy for human genetic disease. Science 1972 Mar 3; 175(25): 949-55.
3. Korthof G. The implications of Steele's soma-to-germline feedback for human gene therapy. http://homeplanetnl/~gkorthof/kortho39ahtm March 1999.
4. Woods NB, Bottero V, Schmidt M, von Kalle C, Verma IM. Gene therapy: therapeutic gene causing lymphoma. Nature 2006 Apr 27; 440(7088): 1123.
5. Clesham GJ. Gene therapy made difficult. Heart 1998 Oct; 80(4): 313-4.
6. Mahato RI, Smith LC, Rolland A. Pharmaceutical perspectives of nonviral gene therapy. Adv Genet 1999; 41: 95-156.
7. Vogels R, Menzo J., E. Havenga, Bout A. Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells. US7968087, 2011.
8. Robertson B LD, Robinson K, Marshall WS, Khyorova A. Apparatus and system having dry gene silencing compositions. US7935811, 2011.
9. Moon JA, Putnam MA. Method of reading encoded particles. US7923260, 2011.
10. Greene LA, Angelastro JM. Methods for promoting apoptosis and treating tumor cells inhibiting the expression or function of the transcription factor ATF5. US7888326, 2011.
11. Anderson WF. Prospects for human gene therapy. Science 1984 Oct 26; 226(4673): 401-9.
12. Payne CS, Roses AD. The molecular genetic revolution. Its impact on clinical neurology. Arch Neurol 1988 Dec; 45(12): 1366-76.
13. Stritzker JH, Hill P, Szalay AA, Yu YA. Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders. US7820184, 2010.
14. Lyerly HK, DiMaio JM. Gene delivery systems in surgery. Arch Surg 1993 Nov; 128(11): 1197-206.
15. Andersen JK, Garber DA, Meaney CA, Breakefield XO. Gene- Transfer into Mammalian Central-Nervous-System Using Herpes- Virus Vectors - Extended Expression of Bacterial Lacz in Neurons Using the Neuron-Specific Enolase Promoter. Human Gene Therapy 1992 Oct; 3(5): 487-99.
16. Morrison HG, Bauer SP, Lange JV, Esposito JJ, McCormick JB, Auperin DD. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology 1989 Jul; 171(1): 179-88.
17. Russell DW, Hirata RK. Targeted gene modification by parvoviral vectors. US7972856, 2011.
18. Gene therapy for human genetic disease? Science 1972 Nov 10; 178(61): 648-9.
19. Selkirk SM. Gene therapy in clinical medicine. Postgrad Med J 2004 Oct; 80(948): 560-70.
20. Stone D, David A, Bolognani F, Lowenstein PR, Castro MG. Viral vectors for gene delivery and gene therapy within the endocrine system. J Endocrinol 2000 Feb; 164(2): 103-18.
21. Lentiviral Vectors: Information and Biosafety Considerations. National Institutes of Health (NIH) documents.
22. Stone D. Novel viral vector systems for gene therapy. Viruses 2010 Apr; 2(4): 1002-7.
23. Venkatesh K. Gene Therapy. Cybermedics 1999.
24. Clayton Biotechnologies Inc - www.claytonbiotech.com. 2009; 06(04).
25. Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther 2002 Dec; 9(24): 1647-52.
26. Houk BE, Hochhaus G, Hughes JA. Kinetic modeling of plasmid DNA degradation in rat plasma. AAPS PharmSci 1999; 1(3): E9.
27. Boeckle S, Wagner E. Optimizing targeted gene delivery: Chemical modification of viral vectors and synthesis of artificial virus vector systems. Aaps J 2006; 8(4): E731-E42.
28. Choi Y. In vivo delivery to tumors of DNA complexed with linear poliethylenimine. Hum Gene Ther 1999; 10: 2657-65.
29. Bielinska AU, Shivdasana RA, Baker JR. Regulation of gene expression with double-stranded phosphothioate oligoncleotides. Biochim Biophys Acta 1997; 1353: 180-90.
30. Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 1996 Dec; 3(12): 1074-80.
31. Erbacher P, Zou S, Bettinger T, Steffan AM, Remy JS. Chitosanbased vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res 1998 Sep; 15(9): 1332-9.
32. Ferrari S, Moro E, Pettenazzo A, Behr JP, Zacchello F, Scarpa M. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Therapy 1997 Oct; 4(10): 1100-6.
33. Smith BF, Baker HJ, Curiel DT, Jiang W, Conry RM. Humoral and cellular immune responses of dogs immunized with a nucleic acid vaccine encoding human carcinoembryonic antigen. Gene Ther 1998 Jul; 5(7): 865-8.
34. Dincer S, Turk M, Piskin E. Intelligent polymers as nonviral vectors. Gene Therapy 2005 Oct; 12: S139-S45.
35. Huang SW, Zhuo RX. Recent progress in polymer-based gene delivery vectors. Chinese Sci Bull 2003 Jul; 48(13): 1304-9.
36. Godbey WT, Wu KK, Mikos AG. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. P Natl Acad Sci USA 1999 Apr 27; 96(9): 5177-81.
37. Midoux P, Pichon C, Yaouanc JJ, Jaffres PA. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Brit J Pharmacol 2009 May; 157(2): 166-78.
38. Schatzlein AG. Targeting of synthetic gene delivery systems. J Biomed Biotechnol 2003 Apr 21(2): 149-58.
39. Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA 1992 Sep 1; 89(17): 7934-8.
40. Midoux P, Mendes C, Legrand A, et al. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucleic Acids Res 1993 Feb 25; 21(4): 871-8.
41. Tu Y, Kim JS. A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes. J Gene Med 2008 Jun; 10(6): 646-54.
42. Twyman L. Polymer and biomaterials laboratories. Dendrimers for Drug and Gene Delivery. http://wwwbiopolymergroupshefacuk/.
43. Lee RJ. Folate-targeted, anionic liposomeentrapped polylysinecondensed DNA for tumor cell-specific gene transfer. J Biol Chem 1996; 271(14): 8481-7.
44. Wang S, Low PS. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Release 1998 Apr 30; 53(1-3): 39-48.
45. Mislick KA, Baldeschwieler JD, Kayyem JF, Meade TJ. Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery. Bioconjug Chem 1995 Sep-Oct; 6(5): 512-5.
46. Guo W, Lee RL. Receptor-targeted gene delivery via folateconjugated polyethylenimine. AAPS PharmSci 1999; 1(4): E19.
47. Wu CH, Wilson JM, Wu GY. Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J Biol Chem 1989 Oct 15; 264(29): 16985-7.
48. Stankovics J, Crane AM, Andrews E, Wu CH, Wu GY, Ledley FD. Overexpression of human methylmalonyl CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/polylysine/DNA complexes. Hum Gene Ther 1994 Sep; 5(9): 1095-104.
49. Stavridis JC, Deliconstantinos G, Psallidopoulos MC, Armenakas NA, Hadjiminas DJ, Hadjiminas J. Construction of transferrincoated liposomes for in vivo transport of exogenous DNA to bone marrow erythroblasts in rabbits. Exp Cell Res 1986 Jun; 164(2): 568-72.
50. Cheng PW. Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum Gene Ther 1996 Feb 10; 7(3): 275-82.
51. Cotten M, Langle-Rouault F, Kirlappos H, Wagner E, Mechtler K, Zenke M, et al. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc Natl Acad Sci USA 1990 Jun; 87(11): 4033-7.
52. Kircheis R, Kichler A, Wallner G, et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 1997 May; 4(5): 409-18.
53. Plank C, Tang MX, Wolfe AR, Szoka FC, Jr. Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. Hum Gene Ther 1999 Jan 20; 10(2): 319-32.
54. Ding ZM, Cristiano RJ, Roth JA, Takacs B, Kuo MT. Malarial Circumsporozoite Protein Is a Novel Gene Delivery Vehicle to Primary Hepatocyte Cultures and Cultured-Cells. J Biochem 1995 Feb 24; 270(8): 3667-76.
55. Sun XY, Frazer IH, Jenson AB, et al. Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol 1995 Feb; 69(2): 948-54.
56. Vaysse L, Guillaume C, Burgelin I, Gorry P, Ferec C, Arveiler B. Proteolipidic vectors for gene transfer to the lung. Biochem Biophys Res Commun 2002 Feb 8; 290(5): 1489-98.
57. Harbottle RP, Cooper RG, Hart SL, Ladhoff A, McKay T, Knight AM, et al. An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. Hum Gene Ther 1998 May 1; 9(7): 1037-47.
58. Xu L, Tang WH, Huang CC, et al. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med 2001 Oct; 7(10): 723-34.
59. Li S, Tan Y, Viroonchatapan E, Pitt BR, Huang L. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol 2000 Mar; 278(3): L504-11.
60. Gupta S, Eastman J, Silski C, Ferkol T, Davis PB. Single chain Fv: a ligand in receptor-mediated gene delivery. Gene Ther 2001 Apr; 8(8): 586-92.
61. DeRome ME, Thomas WL, Robert N, et al. CD5-mediated specific delivery of DNA to T lymphocytes: compartmentalization augmented by adenovirus. J Immunol Methods 1995 Oct 26; 186(2): 257-66.
62. Uherek C FJ, Wels W. A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cellspecific gene delivery. J Biol Chem 1998; 273(15): 8835-41.
63. Wang CY, Huang L. pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc Natl Acad Sci USA 1987 Nov; 84(22):7851-5.
64. Trubetskoy VS, Torchilin VP, Kennel SJ, Huang L. Use of Nterminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells. Bioconjug Chem 1992 Jul-Aug; 3(4): 323-7.
65. Fominaya J, Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J Biol Chem 1996 May 3; 271(18): 10560-8.
66. Choi KH, Kim KJ. Applications of transposon-based gene delivery system in bacteria. J Microbiol Biotechnol 2009 Mar; 19(3): 217-28.
67. Moorlag HE, Van Loenen AM, Meijer DK, et al. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Hum Gene Ther 2004 May; 15(5): 433-43.
68. Curiel DT, Wagner E, Cotten M, et al. High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Hum Gene Ther 1992 Apr; 3(2): 147-54.
69. Kirlappos H, Mechtler K, Curiel DT, et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 1992 Jul 1; 89(13): 6099-103.
70. Yotnda P, Davis AR, Hicks MJ, Templeton NS, Brenner MK. Liposomal enhancement of the antitumor activity of conditionally replication-competent adenoviral plasmids. Mol Ther 2004 Apr; 9(4): 489-95.